Skip to content

usefulness of novel tapered-tip sheath system and peroralcholangioscope in mapping biopsy

Comparative study of the usefulness of novel tapered-tip sheath system and peroralcholangioscope in mapping biopsy - COURAGE STUDY

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1052240296
Enrollment
204
Registered
2025-03-18
Start date
2025-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile duct cancers Bile Duct Neoplasms

Interventions

Preoperative mapping biopsy with EndoSheather or biliary biopsy is assigned.

Sponsors

Tomoaki Matsumori
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All of the following must be met. *Cases in which malignant biliary stricture is suspected and a mapping biopsy with the intention of surgery is necessary. *Cases in which a transpapillary bile duct approach using a lateral endoscope is feasible. *Patients who are undergoing mapping biopsy for the first time at the facility. *Patients 20 years of age or older who have been fully informed about the study and who have given their free and voluntary written consent with full understanding.

Exclusion criteria

Exclusion criteria: *Patients who have already undergone mapping biopsy at the institution. *Cases in which mapping biopsy has already been performed at the institution. (A finding suspicious of pancreatic cancer is a case in which the primary location of the mass is thought to be the pancreas on various imaging tests.) *Cases of reconstructed intestinal tracts after bile duct jejunal anastomosis, Billroth II method of reconstruction, Roux-en-Y method, and other postoperative reconstructive methods. (excluding the Billroth I method). *Cases in which the principal investigator (or subinvestigator) determines that the subject is inappropriate for the study. (e.g., patients considered to be at high risk for acute pancreatitis)

Design outcomes

Primary

MeasureTime frame
Biopsy success rate with assigned devices

Secondary

MeasureTime frame
(1) Time required for biopsy (2) Total procedure time and bile duct intubation time (3) Success rate of biopsy procedure (4) Correct specimen collection rate (5) Contingencies (6) Procedure-related device costs (7) Negative bile duct margins in surgically resected specimens (8) Accuracy of endoscopic findings in POCS

Contacts

Public ContactMatsumori Tomoaki

Kyoto university hospital

tom.matu@kuhp.kyoto-u.ac.jp+81-75-751-4319

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026